Market Overview:
The global carbomer for pharmaceutical market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for carbomer-based products in various applications, such as creams, lotions, and other products. In addition, the growing awareness about the benefits of using these products is also contributing to the growth of this market. Based on type, Carbomer 940 is expected to account for a major share of the global carbomer for pharmaceutical market during the forecast period. This can be attributed to its high viscosity and excellent film-forming properties that make it suitable for use in various applications such as skin care creams and lotions.
Product Definition:
Carbomer is a polymer used as a thickener and stabilizer in pharmaceuticals. It is also used as a binder in tablets and capsules.
Carbomer 940:
Carbomer 940 is a white waxy powder, which is insoluble in water and alkali. It has a strong odor similar to that of acetone. Carbomer 940 has the ability to absorb UV light and convert into a high-energy form called carboxylate radical (OCR). This process makes it more stable than other carbomers such as ethylcarbamate, which are already highly stable compounds.
Carbomer 980:
Carbomer is a polymer with a high degree of branching and linear chains. It has an amorphous structure. Carbomer is used in the production of polymers, adhesives, elastomers, coatings and binders for pharmaceuticals owing to its unique properties such as low glass transition temperature & higher melting point than polyethylene or polypropylene.
Application Insights:
The other application segment includes the use of carbomers in cosmetics and personal care products. The growing demand for creams that are lightweight, non- greasy, and have high moisturizing properties is expected to be a key factor driving the product demand in this segment over the forecast period. In addition, increasing consumer awareness regarding adverse effects associated with parabens is projected to further propel market growth over the next eight years.
North America was estimated as a dominant market for global carbomer for pharmaceutical applications owing to factors such as presence of major manufacturers coupled with rising R&D activities by companies operating in this region. For instance; in April 2017; Dow Chemical Company launched 2 new polymers based on Carbopol family namely Polycarboxylate (Carmopro) and Polycarboxylate (Caprolactam).
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand from personal care, pharmaceuticals, and other industries. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities by major companies for developing new products. Asia Pacific is projected to be the fastest-growing regional market during the same period on account of rapid industrialization and growing population in countries such as China, India, Indonesia among others. Moreover, rising awareness regarding healthcare facilities will propel industry growth further.
Growth Factors:
- Increasing demand for Carbomer in the Pharmaceutical market due to its properties such as thickening, stabilizing, and suspending agents.
- Rising awareness about the benefits of Carbomer in Pharmaceutical products among consumers.
- Growing research and development activities for new applications of Carbomer in Pharmaceuticals industry.
- Technological advancements that would help reduce the manufacturing cost of Carbomer-based products and make them more affordable to consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
Carbomer for Pharmaceutical Market Research Report
By Type
Carbomer 940, Carbomer 980, Carbomer 934, Other
By Application
Creams, Lotions, Other
By Companies
Lubrizol, Tinci Materials, SNF Floerger, Newman Fine Chemical, Evonik, Sumitomo Seika, Corel, DX Chemical, Maruti Chemicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Carbomer for Pharmaceutical Market Report Segments:
The global Carbomer for Pharmaceutical market is segmented on the basis of:
Types
Carbomer 940, Carbomer 980, Carbomer 934, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Creams, Lotions, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lubrizol
- Tinci Materials
- SNF Floerger
- Newman Fine Chemical
- Evonik
- Sumitomo Seika
- Corel
- DX Chemical
- Maruti Chemicals
Highlights of The Carbomer for Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Carbomer 940
- Carbomer 980
- Carbomer 934
- Other
- By Application:
- Creams
- Lotions
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Carbomer for Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Carbomer is a surfactant used in pharmaceuticals. It helps to solubilize and dissolve drugs, making them more effective and easier to administer.
Some of the major companies in the carbomer for pharmaceutical market are Lubrizol, Tinci Materials, SNF Floerger, Newman Fine Chemical, Evonik, Sumitomo Seika, Corel, DX Chemical, Maruti Chemicals.
The carbomer for pharmaceutical market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Carbomer for Pharmaceutical Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Carbomer for Pharmaceutical Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Carbomer for Pharmaceutical Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Carbomer for Pharmaceutical Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Carbomer for Pharmaceutical Market Size & Forecast, 2020-2028
4.5.1 Carbomer for Pharmaceutical Market Size and Y-o-Y Growth
4.5.2 Carbomer for Pharmaceutical Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Carbomer 940
5.2.2 Carbomer 980
5.2.3 Carbomer 934
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Creams
6.2.2 Lotions
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Carbomer for Pharmaceutical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Carbomer for Pharmaceutical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Carbomer 940
9.6.2 Carbomer 980
9.6.3 Carbomer 934
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Creams
9.10.2 Lotions
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Carbomer 940
10.6.2 Carbomer 980
10.6.3 Carbomer 934
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Creams
10.10.2 Lotions
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Carbomer 940
11.6.2 Carbomer 980
11.6.3 Carbomer 934
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Creams
11.10.2 Lotions
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Carbomer 940
12.6.2 Carbomer 980
12.6.3 Carbomer 934
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Creams
12.10.2 Lotions
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Carbomer 940
13.6.2 Carbomer 980
13.6.3 Carbomer 934
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Creams
13.10.2 Lotions
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Carbomer for Pharmaceutical Market: Competitive Dashboard
14.2 Global Carbomer for Pharmaceutical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lubrizol
14.3.2 Tinci Materials
14.3.3 SNF Floerger
14.3.4 Newman Fine Chemical
14.3.5 Evonik
14.3.6 Sumitomo Seika
14.3.7 Corel
14.3.8 DX Chemical
14.3.9 Maruti Chemicals
